Navigation Links
LSUHSC awarded patent for compound inhibiting cancer and other diseases
Date:10/6/2008

New Orleans, LA Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC Professor of Physiology, have been awarded a US Patent for a compound to inhibit the formation of blood vessels critical to the growth of cancerous tumors and diseases like diabetic retinopathy, obesity, and psoriasis.

Apolipoprotein A-I is the major protein component of lipoproteins water soluble carrier molecules that transport cholesterol through the blood. LSUHSC researchers discovered that it can be used to destroy existing blood vessels as well as prevent the development of new vessels. For a tumor to grow bigger than 2 mm, the diameter of a large grain of sand, it must a have blood supply. Application of Apoliporpotein A-1 and high density lipoprotein has been proven effective in inhibiting tumor growth dependent upon angiogenesisthe process of developing new blood vessels. Studies have demonstrated that the level of vascularization in a tumor is strongly associated with metastasis in melanoma, breast, and lung carcinomas.

"This patent was based on the observation that lipid droplets are critical to the formation of the lumen of the blood vessels. By removing these fat droplets from the developing blood vessel we feel that we will be able to control the growth of new blood vessels that would feed tumors," notes Dr. Woltering.

There is also evidence that Apolipoprotein A-1 will be effective in treating other diseases reliant upon angiogenesis. In those diseases, angiogenesis is the root cause of tissue injury, including blindness associated with proliferative retinopathies, skin disorders such as psoriasis, and rheumatoid arthritis. Diseases that have been associated with abnormal blood vessel formation include Crohn's disease, diabetic retinopathy, macular degeneration, obesity, corneal neovascularization, benign tumors,
'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-452-9166
Louisiana State University Health Science Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. LSUHSC awarded $10M+ COBRE grant
2. LSUHSCs Lazartigues awarded $1.2 million grant
3. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
4. 12 McGill researchers awarded Canada Research Chairs
5. Anthony S. Fauci awarded Lasker Award for Public Service
6. ETH Zurich professor Ari Helenius awarded Benoist Prize
7. Nanobiosym awarded $2 million DTRA contract
8. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
9. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
10. $2.7 million awarded for metastatic colon cancer research
11. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 To ... biometric security provider HYPR Corp. announced today the addition of ... will serve as board advisor and David Raviv ... to the team underscore HYPR Corp.,s commitment to providing the ... , Dimitri Sirota co-founded Layer 7 Technologies, a ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... in Spanish . Obese men should ... scientist told the 24th annual conference of the European Society ... A Ghiyath Shayeb, from the University of Aberdeen, Aberdeen, UK, ... higher body mass index (BMI) had lower volumes of seminal ...
... Lauderdale, FL (July 8, 2008) Scientists announced today ... size of the Southern Atlantic Ocean,s largest and richest ... of Brazil,s Bahia state. The newly discovered ... than the previously known Abrolhos reef system, one of ...
... to a new location or go extinct as a result ... in Northern England seem to defy the odds and adapt ... new study by scientists from Syracuse University and the University ... issue of the Early Edition of the Proceedings of ...
Cached Biology News:Obese men have less semen, more sperm abnormalities, and should lose weight before trying for a baby 2Scientists discover new reefs teeming with marine life in Brazil 2New study finds that some plants can adapt to widespread climate change 2
(Date:8/3/2015)... Delaware , August 3, 2015 ... in the commercialization of its Bio-electrical Signal Therapy device ... noninvasive treatment of hard to heal chronic wounds, today ... agreement with Chemipal, an Israeli distributor specializing in medical ... device. Chemipal is a 70 years old, ...
(Date:8/3/2015)... NEW YORK , August 3, 2015 ... "Global Market Study on 3D Cell Culture: ... published by Persistence Market Research, the global 3D cell culture ... is expected to expand at a CAGR of 29.1% ... View Full Report with TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp ...
(Date:8/3/2015)... ... 2015 , ... Sterlitech Corporation introduces the compact, quiet, and ... laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, an oil-free design, ... solution for a broad range of vacuum filtration applications. , Featuring a 1/7 ...
(Date:7/31/2015)... ... 2015 , ... Global Resorcinol Market 2015-2019 is a comprehensive ... global resorcinol industry. The report highlights the various growth prospects and the prevalent ... of primary and secondary inputs from the existing players of the resorcinol market. ...
Breaking Biology Technology:E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4Sterlitech Launches New Line of Vacuum Pumps 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4
... three DFG Research Centres will again be extended and ... made by the Joint Committee of the Deutsche Forschungsgemeinschaft ... Bonn. As a result, the Research Centres established in ... Center for Functional Nanostructures" in Karlsruhe, and "Research Center ...
... (Nasdaq: TPTX ) today reported financial results for ... For the three-month period, the company posted a net loss ... million at March 31, 2009.On April 15, 2009, the Company ... in the evaluation of strategic options, including the possible sale ...
... YORK and NASSAU, The Bahamas, May 1 Fincor ... Prospero Group (Pink Sheets: PRPG) , a leading company ... the new ACTRx Malaria and Dengue fever treatment. Fincor also ... a majority of ACTRx International Inc., which combines several natural ...
Cached Biology Technology:The first DFG research centers to be funded for another 4 years 2The first DFG research centers to be funded for another 4 years 3The first DFG research centers to be funded for another 4 years 4TorreyPines Therapeutics Reports First Quarter 2009 Financial Results 2TorreyPines Therapeutics Reports First Quarter 2009 Financial Results 3TorreyPines Therapeutics Reports First Quarter 2009 Financial Results 4Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment 2